CannNext and Signify to further optimize cannabis production by expanding research collaboration into trichome development
November 5, 2019
- Determine the optimal harvest momentum to optimize crop yield and consistent quality through precise manipulation of a crops’ lighting regime
- The objective is to harvest the highest grade of cannabinoids in its purest form at the exact right moment in consistent conditions to create the highest value for the medicinal end-product.
Eindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, together with long-term research collaboration partner CannNext, is going to optimize crop yield and quality by expanding its joint research program. During the research the two will determine the optimal harvest momentum and lighting regime. In August, Signify and CannNext announced the first phase of their research collaboration to develop growth recipes for high grade medicinal cannabis crops with CannNext.
“We see the cannabis industry evolving at light speed due to the investments involved and increase in legal use in a short time. What may have taken tens of years to get to standards for other crops, this industry clearly has a pace to evolve 10 times faster. Operating our high-tech indoor facility enables us to accelerate research to enhance quality and crop yield,” says Eric Uleman, managing director of CannNext. “We’re used to optimize growth recipes with detailed steering and measuring of irrigation, light, temperature and humidity in the greatest detail necessary to meet standards of GMP production. In this research we focus on finding standards in trichome development to predict content over time and we’ll also leverage technologies from other industries for analysis of trichomes and developing algorithms.”
“We’ve accumulated a wealth of knowledge on how light recipes can advance crops and we’re applying this knowledge to the cultivation of medicinal cannabis. We strongly believe there’s a way we can optimize the harvest moment for a consistent production. In all circumstances this may lead to a significant higher yield of active compounds and secondly improve operational efficiencies,” said Udo van Slooten, Business Leader Horticulture at Signify.
For any medicinal cannabis crop, it is important to understand the right moment for harvesting as this may influence the quality of the flower and therefore its compounds composition. In many cases the harvesting moment is determined by “touch” and “smell”. There is a lot of craftmanship to it, but CannNext and Signify will apply a more technological and systematic approach to help the grower and operations manager in decision making.
Like many other crops, quality attributes are strongly influenced by harvest timing and pre-harvest conditions. Shelf life, dry matter percentage and secondary metabolic contents are rapidly changing when the plant matures and flowers ripens. In our research, we’re monitoring quality aspects of trichomes development on the flower buds during and briefly before harvest in order to draw the right conclusions of the research. Two identical growth containers have been built to conduct the experiments with varying parameters and study the effect of light, irrigation, climate and plant architecture at all phases of the growth process.
For further information, please contact:
Signify Global Marcom Horticulture
Eric Uleman, Managing director
Tel Office +31 (0) 20 767 1950
Signify (Euronext: LIGHT) is the world leader in lighting for professionals and consumers and lighting for the Internet of Things. Our Philips products, Interact connected lighting systems and data-enabled services, deliver business value and transform life in homes, buildings and public spaces. With 2018 sales of EUR 6.4 billion, we have approximately 27,000 employees and are present in over 70 countries. We unlock the extraordinary potential of light for brighter lives and a better world. We have been named Industry Leader in the Dow Jones Sustainability Index for three years in a row. News from Signify is located at the Newsroom, Twitter, LinkedIn and Instagram. Information for investors can be found on the Investor Relations page.
CannNext has an ultramodern facility in the Netherlands that is capable of producing standardized medicinal cannabis and conducts research into THC and CBD components in cannabis plants to ultimately improve the well-being of patients. CannNext conducts research with its customers and also advises international companies and governments on the construction, design and operation of high-end cultivation facilities in accordance with strict regulations and procedures. CannNext has received a permit from the Dutch government for conducting research. This license is issued in the Netherlands by the Ministry of Health, Welfare and Sport. News can be found at Twitter and our News page.